Physician profile
Michael E Carley
NPI 1225053622
$7,041.18
in general payments reported to CMS, 2019-2025
29 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $277 · 2021: $2,830 · 2022: $1,494 · 2023: $527 · 2024: $613 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,240.06 | 2019-2022 | |
| Abbvie INC. | $820.81 | 2022-2025 | Botox |
| Astellas Pharma US INC | $461.81 | 2019-2025 | Veozah |
| Medtronic, INC. | $381.52 | 2021-2024 | Interstim |
| Sumitomo Pharma America, INC. | $373.62 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $282.96 | 2021-2023 | Desara |
| Urovant Sciences INC | $270.73 | 2021-2022 | |
| Boston Scientific Corporation | $243.07 | 2019-2025 | Enhance Transcarotid Peripheral Access Kit |
| Axonics, INC. | $176.93 | 2020-2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $100.38 | 2019-2020 | |
| Intuitive Surgical, INC. | $89.51 | 2024 | |
| Rochester Medical Corporation | $80.33 | 2020-2022 | |
| Avation Medical, INC. | $64.28 | 2024-2025 | Vivally System, Vivally |
| Therapeuticsmd, INC. | $54.26 | 2019-2020 | |
| Millicent US INC | $52.30 | 2021-2023 | Intrarosa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $46.78 | 2019 | |
| Ferring Pharmaceuticals INC. | $40.91 | 2019 | |
| Coloplast Corp | $37.42 | 2021-2024 | |
| Valencia Technologies Corporation | $34.11 | 2025 | Ecoin Device Kit |
| Ethicon US, LLC | $32.78 | 2021 | |
| Duchesnay USA Incorporated | $30.83 | 2019 | |
| Davol INC. | $23.57 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.94 | 2024 | |
| Bluewind Medical | $17.31 | 2025 | Revi |
| Merck Sharp & Dohme LLC | $14.23 | 2022 | |
| Pfizer INC. | $12.82 | 2019 | |
| Biolase, INC. | $12.49 | 2021 | |
| Acessa Health INC. | $11.38 | 2019 | |
| Ambu INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.